Profiling of driver mutations in lung adenocarcinoma patients identifies rare compound EGFR mutations sensitive to second-generation EGFR-TKIs
Abstract Background Lung adenocarcinoma (LUAD) is the most predominant histological subtype of lung cancer characterized by driver mutations detected in a substantial proportion of the cases. Tyrosine kinase inhibitors (TKIs) are standard care for the patients with these mutations. In this study, we...
        Saved in:
      
    
          | Main Authors: | , , , , , , , , , , , , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Springer
    
        2024-12-01 | 
| Series: | Holistic Integrative Oncology | 
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s44178-024-00139-z | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
 
       